Revelation Biosciences
REVB
7 hedge funds and large institutions have $64.2K invested in Revelation Biosciences in 2025 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
382% more capital invested
Capital invested by funds: $13.3K → $64.2K (+$50.9K)
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
0.66% more ownership
Funds ownership: 0.08% → 0.74% (+0.66%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$143K |
| 2 |
SG
StoneX Group
New York
|
+$22.3K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.5K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.14K |
| 5 |
SS
SBI Securities
Tokyo,
Japan
|
+$1.88K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
-$1.61K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$26 |
REVB Hedge Fund Activity: Q2 2025 in Review
7 institutional investors reported a position in Revelation Biosciences (REVB) for Q2 2025, worth a combined $64.2K — up 382% from $13.3K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new REVB positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $143K. The largest seller was IFP Advisors, exiting entirely with an estimated $1.61K sold.
- 7 institutional investors held Revelation Biosciences (REVB) as of Q2 2025, up from 6 in Q1 2025.
- Funds reported $64.2K of Revelation Biosciences stock for Q2 2025, up 382% quarter-over-quarter.
- 2 funds opened new Revelation Biosciences positions in Q2 2025 and 1 closed out, a net change of +1 holder.
- The largest Revelation Biosciences buyer in Q2 2025 was Sabby Management, an estimated $143K added.
- The largest Revelation Biosciences seller in Q2 2025 was IFP Advisors, an estimated $1.61K sold.
Based on aggregated 13F filings for Q2 2025.